Please assess the completion status of the following clinical trial:

Trial Title: Ketamine Improves Post-Thoracotomy Analgesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Consecutive patients scheduled for elective minimally invasive direct coronary artery bypass (MIDCAB) or for lung resection via anterolateral thoracotomy during a 6-month period (Sep 2001-March 2002)~Exclusion Criteria:~Exclusion criteria were:~* American Society of Anesthesiologists (ASA) physical class ≥3, Emergency operations,~* Q-wave myocardial infarct occurring during the previous 3 weeks, or poor left ventricular function (e.g., ejection fraction \[EF\] \<30% by echocardiography or angiography).~Other exclusion criteria were:~* A body mass index \>35 kg/m2,~* Past or current neuropathy or psychological disturbances,~* The use of centrally active drugs,~* Chronic liver or renal failure requiring dialysis,~* A FEV1/FVC \<70%,~* Allergy to ketamine, morphine or non steroidal anti inflammatory drugs (NSAIDs),~* Clotting abnormalities,~* A platelets count \<70000/mm3,~* A white blood count \<3000\>14000/mm3,~* Uncontrolled diabetes mellitus or fasting blood glucose \>250 g/dl,~* Evidence of sepsis or infection up to one week prior to randomization.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- morphine only (Type: ACTIVE_COMPARATOR): standard analgesia protocol
- morphine ketamine (Type: EXPERIMENTAL): alterantive regimen for intravenous patient controlled analgesia

Based on this trial design, predict the completion outcome and termination type (if applicable).